- The study investigated the genetic inter-relationships among various psychiatric and substance use disorders.
- Researchers used comprehensive Swedish national register data to analyze 12 disorders across two genetic risk dimensions.
- Disorders segregated into two clusters: internalizing disorders with moderate MD and low DUD genetic liability, and externalizing disorders with substantial risk for both.
- The authors concluded that genetic liabilities for these disorders are not fixed but vary systematically with clinical features.
- These findings offer a framework for understanding cross-disorder relationships, potentially informing diagnostic and prognostic considerations.
Untangling the Genetic Threads of Psychiatric Disorders
Psychiatric and substance use disorders frequently co-occur, presenting complex diagnostic and treatment challenges for clinicians who observe overlapping symptom profiles daily [1, 2]. While research has identified significant heritable components for individual conditions like major depression (MD) and problematic alcohol use [3, 4], and polygenic risk scores have hinted at shared liabilities [5, 6, 7], the genetic architecture underlying this widespread comorbidity remains incompletely understood. Environmental factors and life events further complicate this picture [8, 9]. A recent study using comprehensive Swedish national register data offers a more structured view of these relationships by mapping multiple disorders onto a framework defined by shared genetic risks [10].
Mapping Genetic Risk: A Two-Dimensional Framework
To clarify the genetic overlap among common psychiatric conditions, the researchers developed a two-dimensional map. This analytical framework positions different disorders in a space defined by two fundamental axes: family-based genetic risk for major depression (MD) and family-based genetic risk for drug use disorder (DUD). Using these two core disorders as reference points, the study leveraged extensive Swedish national register data to plot the relative genetic position of 12 distinct psychiatric and substance use disorders. This method provides a visual and quantitative representation of how much each disorder's genetic liability is shared with MD, DUD, or both. The study also investigated how these genetic risk profiles are modulated by key clinical variables, including the patient's sex, age at symptom onset, and the recurrence of the disorder, providing a more dynamic picture of how genetic predispositions manifest clinically.
Two Core Clusters of Psychiatric Disorders Emerge
The genetic mapping analysis revealed a clear and robust organization, with the 12 disorders segregating into two distinct clusters. This finding suggests a fundamental biological structure underlying the commonly observed patterns of psychiatric comorbidity. The first group, composed of internalizing disorders, was defined by a profile of moderate genetic liability for major depression (MD) combined with low genetic liability for drug use disorder (DUD). The second group, comprising externalizing disorders, showed a different signature: substantial genetic risk along both the MD and DUD axes. The placement of specific disorders provided clinical context to these genetic groupings. For example, post-traumatic stress disorder (PTSD) grouped with the internalizing cluster, consistent with its frequent depressive features. In contrast, borderline personality disorder aligned with the externalizing group, reflecting a genetic predisposition linked to both mood dysregulation and substance use risk. The stability of these clusters was confirmed as the patterns were replicated across different regions of Sweden, underscoring the reliability of the findings.
Sex-Specific Genetic Liabilities in Psychiatric Disorders
The investigation uncovered that sex differences in genetic liability were common and often complex, involving variations along both the MD and DUD risk axes. A consistent and clinically relevant pattern emerged: for many disorders, the sex with the lower overall prevalence was found to carry a higher aggregate genetic risk. This suggests that a greater genetic load may be required to surpass a higher biological or social threshold for the disorder's expression in the less-frequently affected sex. This disparity was most pronounced for alcohol use disorder (AUD) and drug use disorder (DUD). For a clinician, this implies that the genetic contribution to a disorder like AUD may be stronger in a female patient than in a male patient, a factor that could inform prognosis, risk assessment for family members, and treatment planning.
Age of Onset and Recurrence Modulate Genetic Risk
The study demonstrated that genetic risk is not a static value but is significantly associated with the clinical course of an illness. A key finding was that across most disorders, an earlier age of onset was associated with elevated genetic liability. This effect was particularly strong for alcohol use disorder (AUD), major depression (MD), and post-traumatic stress disorder (PTSD). This suggests that patients presenting with these conditions in adolescence or early adulthood may carry a greater genetic burden, a factor that could influence decisions regarding the intensity and duration of early intervention. In a similar vein, a high level of recurrence consistently indexed increased genetic risk, often spanning both the MD and DUD axes. This was especially prominent for AUD, DUD, MD, and PTSD. For physicians, a patient's history of multiple episodes serves as a clinical marker for a more significant underlying genetic vulnerability, which has direct implications for prognosis and the importance of maintenance therapies to prevent relapse.
Dynamic Genetic Liabilities and Clinical Relevance
Ultimately, these findings indicate that the genetic liabilities for psychiatric and substance use disorders are not fixed entities. Instead, they vary systematically with key clinical features like a patient's sex, age at onset, and history of recurrence. This dynamic perspective moves beyond a simple binary view of genetic risk. For a practicing physician, it means that a patient's specific clinical profile provides important clues about the strength of their underlying genetic predisposition. The study's method of considering multiple genetic risks simultaneously, using MD and DUD as foundational axes, offers a more sophisticated framework for understanding the complex web of cross-disorder relationships. This approach provides a biological rationale for the clustering of internalizing and externalizing disorders and clarifies the genetic position of conditions like PTSD and borderline personality disorder. This refined understanding of genetic architecture may help clinicians better assess risk and prognosis, moving beyond single-disorder diagnoses toward a more integrated view of a patient's total psychiatric vulnerability.
References
1. Caserini C, Ferro M, Nobile M, Scaini S, Michelini G. Shared genetic influences between depression and conduct disorder in children and adolescents: A systematic review.. Journal of Affective Disorders. 2022. doi:10.1016/j.jad.2022.11.001
2. Moyakhe L, Dalvie S, Mufford M, Stein D, Koen N. Polygenic risk associations with developmental and mental health outcomes in childhood and adolescence: A systematic review. medRxiv. 2023. doi:10.1101/2023.03.31.23287877
3. Howard DM, Adams MJ, Clarke T, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nature Neuroscience. 2019. doi:10.1038/s41593-018-0326-7
4. Zhou H, Sealock J, Sanchez‐Roige S, et al. Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. Nature Neuroscience. 2020. doi:10.1038/s41593-020-0643-5
5. Mistry S, Harrison JR, Smith DJ, Escott-Price V, Zammit S. The use of polygenic risk scores to identify phenotypes associated with genetic risk of schizophrenia: Systematic review.. Schizophrenia research. 2018. doi:10.1016/j.schres.2017.10.037
6. Mistry S, Harrison JR, Smith DJ, Escott-Price V, Zammit S. The use of polygenic risk scores to identify phenotypes associated with genetic risk of bipolar disorder and depression: A systematic review.. Journal of affective disorders. 2018. doi:10.1016/j.jad.2018.02.005
7. Dezhina Z, Ranlund S, Kyriakopoulos M, Williams S, Dima D. A systematic review of associations between functional MRI activity and polygenic risk for schizophrenia and bipolar disorder. Brain Imaging and Behavior. 2018. doi:10.1007/s11682-018-9879-z
8. Varese F, Smeets F, Drukker M, et al. Childhood Adversities Increase the Risk of Psychosis: A Meta-analysis of Patient-Control, Prospective- and Cross-sectional Cohort Studies. Schizophrenia Bulletin. 2012. doi:10.1093/schbul/sbs050
9. Modabbernia A, Velthorst E, Reichenberg A. Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses. Molecular Autism. 2017. doi:10.1186/s13229-017-0121-4
10. Kendler KS, Ohlsson H, Amstadter AB, Sundquist J, Sundquist K. The typology of common psychiatric disorders as depicted by genetic maps: a study based on Swedish population-based registers.. World psychiatry : official journal of the World Psychiatric Association (WPA). 2026. doi:10.1002/wps.70074